Tamazoust Guiddir1, Philippe Saint-Pierre2, Elsa Purenne-Denis3, Nathalie Lambert1, Yacine Laoudi3, Rémy Couderc4, Rahelé Gouvis-Echraghi3, Flore Amat1, Jocelyne Just5. 1. Allergology Department, Armand Trousseau Children Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France; University Paris 06, Sorbonne University, Paris, France. 2. Institute of Mathematics, Toulouse III Paul-Sabatier University, Toulouse, France. 3. Allergology Department, Armand Trousseau Children Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France. 4. Biochemistry Laboratory, Armand Trousseau Children Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France. 5. Allergology Department, Armand Trousseau Children Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France; University Paris 06, Sorbonne University, Paris, France. Electronic address: jocelyne.just@aphp.fr.
Abstract
BACKGROUND: Little is known about inflammatory pathways of severe recurrent wheeze in preschool children and severe asthma in children. OBJECTIVES: The aim of the Severe Asthma Molecular Phenotype cohort was to characterize phenotypes of severe recurrent wheeze and severe asthma during childhood in terms of triggers (allergic or not), involved cells (eosinophil or neutrophil), and corticoid responsiveness. METHODS: Children with moderate-to-severe asthma and preschool children with moderate-to-severe recurrent wheeze were enrolled prospectively. They underwent standardized clinical and blood workup, and bronchoalveolar lavage (BAL) evaluation. Cluster analysis was applied to 350 children with 34 variables. RESULTS: Three clusters were identified: cluster 1, Neutrophilic steroid-refractory recurrent wheeze phenotype, with 138 children uncontrolled despite high-dose inhaled corticosteroids (ICS) (92%, P < .001), with more history of pneumonia (31%, P < .001), more gastroesophageal reflux disease (37%, P < .001), and the highest blood neutrophil count (mean 4.524 cells/mm3, P = .05); cluster 2, Severe recurrent wheeze with sensitization to a single aeroallergen (12%, P = .002), with 104 children controlled with high-dose ICS (63%, P < .001); cluster 3, Eosinophilic steroid-refractory asthma phenotype, with 108 children uncontrolled despite high-dose ICS (76%, P < .001) with more allergic rhinitis, atopic dermatitis, and food allergies (82%, 40%, 31%, P < .001, respectively). They also had a higher blood eosinophil count and a higher percentage of BAL eosinophil (506/mm3, 2.6%, P < .001 respectively). CONCLUSIONS: Inflammation pathway of asthma and recurrent wheeze are related to eosinophil cells in older children and neutrophil cells in younger children. These results could improve personalized treatments.
BACKGROUND: Little is known about inflammatory pathways of severe recurrent wheeze in preschool children and severe asthma in children. OBJECTIVES: The aim of the Severe Asthma Molecular Phenotype cohort was to characterize phenotypes of severe recurrent wheeze and severe asthma during childhood in terms of triggers (allergic or not), involved cells (eosinophil or neutrophil), and corticoid responsiveness. METHODS:Children with moderate-to-severe asthma and preschool children with moderate-to-severe recurrent wheeze were enrolled prospectively. They underwent standardized clinical and blood workup, and bronchoalveolar lavage (BAL) evaluation. Cluster analysis was applied to 350 children with 34 variables. RESULTS: Three clusters were identified: cluster 1, Neutrophilic steroid-refractory recurrent wheeze phenotype, with 138 children uncontrolled despite high-dose inhaled corticosteroids (ICS) (92%, P < .001), with more history of pneumonia (31%, P < .001), more gastroesophageal reflux disease (37%, P < .001), and the highest blood neutrophil count (mean 4.524 cells/mm3, P = .05); cluster 2, Severe recurrent wheeze with sensitization to a single aeroallergen (12%, P = .002), with 104 children controlled with high-dose ICS (63%, P < .001); cluster 3, Eosinophilic steroid-refractory asthma phenotype, with 108 children uncontrolled despite high-dose ICS (76%, P < .001) with more allergic rhinitis, atopic dermatitis, and food allergies (82%, 40%, 31%, P < .001, respectively). They also had a higher blood eosinophil count and a higher percentage of BAL eosinophil (506/mm3, 2.6%, P < .001 respectively). CONCLUSIONS: Inflammation pathway of asthma and recurrent wheeze are related to eosinophil cells in older children and neutrophil cells in younger children. These results could improve personalized treatments.
Authors: Jocelyn R Grunwell; Susan T Stephenson; Rabindra Tirouvanziam; Lou Ann S Brown; Milton R Brown; Anne M Fitzpatrick Journal: J Allergy Clin Immunol Pract Date: 2018-09-05
Authors: John W Steinke; Monica G Lawrence; W Gerald Teague; Thomas J Braciale; James T Patrie; Larry Borish Journal: J Allergy Clin Immunol Date: 2020-06-09 Impact factor: 14.290
Authors: Lucy Pembrey; Mauricio L Barreto; Jeroen Douwes; Philip Cooper; John Henderson; Harriet Mpairwe; Cristina Ardura-Garcia; Martha Chico; Collin Brooks; Alvaro A Cruz; Alison M Elliott; Camila A Figueiredo; Sinéad M Langan; Beatrice Nassanga; Susan Ring; Laura Rodrigues; Neil Pearce Journal: ERJ Open Res Date: 2018-08-22
Authors: Anne M Fitzpatrick; Leonard B Bacharier; Daniel J Jackson; Stanley J Szefler; Avraham Beigelman; Michael Cabana; Ronina Covar; Theresa Guilbert; Fernando Holguin; Robert F Lemanske; Fernando D Martinez; Wayne Morgan; Wanda Phipatanakul; Jacqueline A Pongracic; Hengameh H Raissy; Robert S Zeiger; David T Mauger Journal: J Allergy Clin Immunol Pract Date: 2020-03-07
Authors: Atul Gupta; Isabelle Pouliquen; Daren Austin; Robert G Price; Rodger Kempsford; Jonathan Steinfeld; Eric S Bradford; Steven W Yancey Journal: Pediatr Pulmonol Date: 2019-09-09
Authors: Jisun Yoon; Eun Jin Eom; Jin Tack Kim; Dae Hyun Lim; Woo Kyung Kim; Dae Jin Song; Young Yoo; Dong In Suh; Hey Sung Baek; Meeyong Shin; Ji Won Kwon; Gwang Cheon Jang; Hyeon Jong Yang; Eun Lee; Hwan Soo Kim; Ju Hee Seo; Sung Il Woo; Hyung Young Kim; Youn Ho Shin; Ju Suk Lee; Sungsu Jung; Minkyu Han; Jinho Yu Journal: Allergy Asthma Immunol Res Date: 2021-01 Impact factor: 5.764